Agenda

Return

C. 73

To:	Board of Supervisors
From:	William Walker, M.D., Health Services Director
Date:	August 1, 2017

Contra

Costa

County

Subject:

Purchase Order for Med One Capital, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 08/01/2017

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Anna Roth, 925-370-5101
cc:	Tasha Scott Marcy Wilhelm Margaret Harris

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: August 1, 2017
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

Approve and authorize the Purchasing Agent, on behalf of the Health Services Department, to execute a Purchase Order with Med One Capital, Inc. in an amount not to exceed $136,000, for lease of the Flex Lock with Temp Check for use by the pharmacy at Contra Costa Regional Medical Center (CCRMC), for the period of August 1, 2017 through July 31, 2022.

FISCAL IMPACT:

100% funded by Hospital Enterprise Fund I.

BACKGROUND:

CCRMC has used Omnicell since 2005 in the hospital and clinics. These Flex locks with Temp Check are used to secure the medication refrigerators to the Omnicell and also monitor the temperature of the refrigerator. CCRMC will be leasing the Omnicell equipment through Med One Capital Funding. CCRMC has been satisfied with Omnicell as a vendor over the past 10 years and wishes to continue using this company. Omnicell has assisted CCRMC to reach the Medication Safety and Patient Safety goals set for patient population and has brought CCRMC to the compliance with the regulatory requirements.

CONSEQUENCE OF NEGATIVE ACTION:

If this Purchase Order is not approved, there will be a lack of a safe and effective medication storage and distribution system which could result in unsafe medication practices, potential costly regulatory citations, or patient harm.